ELRIG's Therapeutic OLIGOs and European Chemical Biology Symposium 2023
Poster
58

Characterization of anti-cancer effects for novel benzodiazepine derivatives

Abstract

Benzodiazepines are well known as a key scaffold in medicinal chemistry providing bioactive compounds for a variety of biological targets. Among their primary use as anxiolytics and sedatives, the 1,4-benzodiazepine derivatives and their metabolites play a role as antitumor, antiviral and antimalarial agents. Recent studies revealed the influence of the benzodiazepine derivatives on the microtubule assembly or stability with subsequent mitotic failure. These microtubule-targeting effects were evaluated in novel benzodiazepine derivatives. The antiproliferative activities of novel derivatives were tested against a panel of 10 cancer cell lines and 2 non-cancer cell lines. The compounds with IC50

supporting document

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the Apple or Google Store and search for 'myEventflo'
iPhone App
Android App
www.myeventflo.com/2472